Country, language and currency
- Social bookmarks:
- Testimonials
-
Read more »
Our billing is certified by:
-
- Orion Sues Mylan In US To Enforce Parkinson's Drug Patents - Fox Business
- Orion Sues Mylan In US To Enforce Parkinson's Drug PatentsFox Business-Mylan seeks authorisation to produce and market generic tablets in the United States, with carbidopa, levodopa and entacapone as active ingredients in the same proportion as in Orion's Stalevo
- Orion sues Mylan in the US to enforce its US patents covering the proprietary ... - Reuters
- Orion sues Mylan in the US to enforce its US patents covering the proprietary
- A 64-Year-Old Man With Motor Complications of Advanced Parkinson Disease - Journal of American Medical Association (subscription)
- A 64-Year-Old Man With Motor Complications of Advanced Parkinson DiseaseJournal of American Medical Association (subscription)His current medication regimen is carbidopa/levodopa/entacapone 31
- Orion Sues Mylan In US To Enforce Parkinson's Drug Patents - Capital.gr (press release)
- Orion Sues Mylan In US To Enforce Parkinson's Drug PatentsCapital
